Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read July's edition from Kinapse.
Blockchain could revolutionise the pharma supply chain, solving big issues in logistics, counterfeiting, and patient usage. Follow the link to find out how.
Threatened by innovative biotech organisations, Pharma companies need to accelerate their patient centricity initiatives or risk falling behind.
In the first of a four part blog series, we outline what blockchain is, and what applications it could present to the Pharmaceutical industry.
Fuelled by media scrutiny, drug affordability is becoming an increasingly powerful influence in market access decisions today. Learn how to overcome it.
Lean Biotechs and patients themselves are using new technology to revolutionise the patient experience. In order to keep up, Pharma needs to significantly accelerate and strengthen its value proposition in the digital space.
Health Canada have drafted a guidance document relating to the planned public release of clinical trial documents, broadly in line with EMA Policy 0070. What are the key differences? How should your organisation prepare?
Plain language summaries of clinical study reports must be understood by lay readers and clinical experts. How should organisations strike the balance?